Cambridge, Mass. — Vyome Holdings, Inc., a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, has appointed Jerry Leonard, CPA, MBA, as Chief Financial Officer.
Leonard assumed the role on Sept. 1 and will oversee the company’s financial operations, reporting, accounting, internal controls and related corporate governance responsibilities. He succeeds Robert Dickey IV, who had served as Interim Chief Financial Officer since August 2025.
“Jerry brings a strong combination of public company financial leadership, operating discipline and experience in reporting, financial operations, and governance that we believe is particularly relevant to Vyome as we continue to build our organization,” said Venkat Nelabhotla, Chief Executive Officer of Vyome Holdings. “His experience across emerging public companies as well as large global organizations will be valuable in strengthening our financial processes and controls and supporting disciplined execution as we advance our development programs.”
Leonard brings more than 25 years of experience in financial management, business leadership and corporate strategy. He is the Founder and Chief Executive Officer of ClearBridgeCFO, a financial leadership and transformation firm.
Previously, he served as Senior Vice President, Chief Financial Officer and Secretary of VSee Health following its 2024 business combination. Before that, he was Chief Financial Officer of iDoc Virtual Telehealth Solutions and VSee Lab.
Earlier in his career, Leonard spent more than a decade as Vice President of Finance within the asset management business of Voya Financial and held finance leadership positions at IBM and Colgate-Palmolive. He began his career in public accounting at Arthur Andersen and PricewaterhouseCoopers.
Leonard is a Certified Public Accountant and holds an MBA from Emory University’s Goizueta Business School.
“Vyome has built a disciplined financial foundation as it continues to advance its development pipeline,” Leonard said. “I look forward to working with Vyome’s executive team, the Board and the broader team to further strengthen the Company’s financial operations, reporting, controls and governance, while supporting the organization as it continues to grow and execute on its strategic priorities.”
